Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) [NA]
Trial update for the EXACT2 study evaluating exercise to prevent anthracycline-induced cardiotoxicity in breast cancer patients; the trial i…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer [NA]
This entry describes a clinical trial evaluating a physical activity program intended to improve quality of life and reduce fatigue in metas…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: The ClearCoast™ Magnetic Resonance Outcome PMS Study
Clinical trial update indicating the ClearCoast Magnetic Resonance Outcome PMS Study in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy [NA]
This clinical trial update notes the termination of NCT04363892, a study evaluating combined optical and infrared imaging to predict erythem…
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Music Therapy in Patients With Breast Cancer- a Randomized Controlled Trial [NA]
A randomized controlled trial evaluating music therapy in breast cancer patients with anxiety and fatigue has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer [NA]
Clinical trial evaluating vitamin B12 for aromatase inhibitor–associated musculoskeletal symptoms in hormone receptor-positive breast cancer…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial [Phase 2]
A Phase 2 randomized open-label trial compares combination therapy followed by maintenance chemotherapy versus a CDK4/6 inhibitor combined w…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of TQB2102 for injection versus investigator-selected chemotherapy in HER2-low expressing…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer
This clinical trial update reports on PD-L1 expression in HER2-positive breast cancer and triple-negative breast cancer. The study is active…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization [NA]
A completed clinical trial evaluated improved breast radiotherapy setup and delivery using mixed-reality visualization. Results have been po…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer [NA]
A clinical trial is evaluating the effectiveness and safety of single-port robotic-assisted breast surgery for breast cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg [Phase 4]
Phase 4 bioequivalence study comparing Palbociclib 125 mg capsules produced by Megalabs (Iclos) with the reference Ibrance 125 mg capsules (…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
This clinical trial update reports the completion of a study evaluating treatment patterns and outcomes in participants with HER2-positive u…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer [NA]
A completed clinical trial by the Austrian Breast & Colorectal Cancer Study Group studied synchronous metastatic breast cancer and circulati…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping [Phase 2]
Phase 2 trial exploring precision treatment for HR+ HER2- advanced breast cancer using SNF molecular subtyping; the study is not yet recruit…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer [Phase 1, Phase 2]
A clinical trial update indicates the APG-2575 study for breast cancer and solid tumors (Phase 1/Phase 2) has been suspended by sponsor Asce…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Comparison of Pre-op and Post-op Pectoralis Nerve Block [NA]
This completed clinical trial compared preoperative versus postoperative pectoralis nerve blocks in breast cancer surgery; results were post…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
This clinical trial update reports real-world outcomes and toxicity in metastatic breast cancer patients treated with first- or second-line …
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Feasibility of Fasting & Exercise in Pts With HR+ MBC [NA]
Completed clinical trial evaluating the feasibility of fasting and exercise in patients with hormone receptor-positive metastatic breast can…
-
FDA approval · 2024-08-16FDA Approved: LAPATINIB — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's original application for a generic version of lapatinib for HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) [Phase 3]
A Phase 3 study evaluating tibolone (Livial) on breast tissue in postmenopausal women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: ICG and SLN Mapping [EARLY_Phase 1]
An early-phase trial update reporting results from a Phase 1 study evaluating indocyanine green (ICG) for sentinel lymph node mapping in bre…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: MicroRNAs and Prognosis in Breast Cancer
This update reports on a completed clinical trial investigating the relationship between microRNA profiles and prognosis in breast cancer.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
Clinical trial evaluating the safety of acellular dermal matrix (ADM) in breast reconstruction is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction
A clinical trial is evaluating the effectiveness and safety of SC DERM Recon acellular dermal matrix for breast reconstruction and is curren…